FIORUCCI, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 434
EU - Europa 240
AS - Asia 143
AF - Africa 1
Totale 818
Nazione #
US - Stati Uniti d'America 433
IE - Irlanda 84
IT - Italia 71
VN - Vietnam 42
HK - Hong Kong 38
CN - Cina 31
FR - Francia 23
SG - Singapore 23
RU - Federazione Russa 13
DE - Germania 10
AT - Austria 6
GB - Regno Unito 6
UA - Ucraina 6
BE - Belgio 5
NL - Olanda 5
FI - Finlandia 3
SE - Svezia 3
TR - Turchia 3
AL - Albania 2
KR - Corea 2
LB - Libano 2
UZ - Uzbekistan 2
CA - Canada 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
RO - Romania 1
Totale 818
Città #
Chandler 132
Dublin 84
San Mateo 53
Dong Ket 42
Hong Kong 38
Ann Arbor 31
Medford 21
Perugia 21
Princeton 20
Singapore 20
Andover 16
Altamura 15
Beijing 15
Wilmington 14
Lawrence 13
Ashburn 6
Saint Petersburg 6
Brussels 5
Den Haag 5
Redmond 5
Redwood City 5
Vienna 5
Norwalk 4
Cambridge 3
Izmir 3
Chicago 2
Dearborn 2
Florence 2
Helsinki 2
Seoul 2
Stroncone 2
Woodbridge 2
Abidjan 1
Avignon 1
Castiglione del Lago 1
Cormeilles-en-Parisis 1
Esslingen am Neckar 1
Hefei 1
Houston 1
Iglesias 1
Jacksonville 1
Jinan 1
Lappeenranta 1
Lausanne 1
Lexington 1
Los Angeles 1
Magdeburg 1
Nanjing 1
Napoli 1
Olomouc 1
Portland 1
Radeberg 1
Timisoara 1
Tiranë 1
Toronto 1
Viterbo 1
Zevio 1
Zhengzhou 1
Totale 622
Nome #
The aryl hydrocarbon receptor (AhR) mediates the counter-regulatory effects of pelargonidins in models of inflammation and metabolic dysfunctions 71
Agonism for the bile acid receptor GPBAR1 reverses liver and vascular damage in a mouse model of steatohepatitis 57
Sa1518 – Mechanism of Acute Liver Decompensation Caused by Obeticholic Acid in Cholestasis is Fxr Dependent 53
241 - GPBAR1 (TGR5) is a Modulator of Liver Immunity and Reverses Liver Inflammation in a Mouse Models of Acute Hepatitis 51
Su1053 - Bar704, a Potent and Selective Fxr Agonist Protects Against Intestinal Fibrosis 49
Tu1546 – Gpbar1 is a Modulator of Liver Immunity and Its Agonism Reverses Acetaminophen-Induced Hepatotoxicity by Modulating Recruitment of Liver Macrophages 49
Genetic and Pharmacological Dissection of the Role of Spleen Tyrosine Kinase (Syk) in Intestinal Inflammation and Immune Dysfunction in Inflammatory Bowel Diseases 48
Mo2014 – Comparative Effects of Bar502, a Dual Fxr and Gpbar1 Agonist, Obeticholic Acid and Ursodeoxycholic Acid in a Rodent Model of Nash 48
Glucocorticoid-induced leucine zipper regulates liver fibrosis by suppressing CCL2-mediated leukocyte recruitment 48
Tu1738 - The Aryl Hydrocarbon Receptor Mediates Anti-Inflammatory Activities of Natural and Synthetic Pelargonidines in Mouse Models of Colitis 44
The Bile Acid Receptor GPBAR1 Modulates CCL2/CCR2 Signaling at the Liver Sinusoidal/Macrophage Interface and Reverses Acetaminophen-Induced Liver Toxicity 43
Ursodeoxycholic acid is a GPBAR1 agonist and resets liver/intestinal FXR signaling in a model of diet-induced dysbiosis and NASH 42
Divergent effectiveness of multispecies probiotic preparations on intestinal microbiota structure depends on metabolic properties 39
Opposite effects of the FXR agonist obeticholic acid on Mafg and Nrf2 mediate the development of acute liver injury in rodent models of cholestasis 39
Transcriptome Analysis of Dual FXR and GPBAR1 Agonism in Rodent Model of NASH Reveals Modulation of Lipid Droplets Formation 35
Tu1748 - Probiotics Beyond Taxonomy: Evidence that Anti-inflammatory Properties of Live Biotherapeutic Products Require Phenotypic Characterization 33
Novel Isoxazole Derivatives with Potent FXR Agonistic Activity Prevent Acetaminophen-Induced Liver Injury 33
GPBAR1 (TGR5) AGONISM REVERSES ENDOTHELIAL DYSFUNCTION AND LIVER INJURY IN A DIETETIC MODEL OF STEATOHEPATITIS 32
GPBAR1 Functions as Gatekeeper for Liver NKT Cells and provides Counterregulatory Signals in Mouse Models of Immune-Mediated Hepatitis 31
The bile acid activated receptors GPBAR1 and FXR exert antagonistic effects on autophagy 28
Totale 873
Categoria #
all - tutte 3.951
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.951


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202062 4 7 3 0 3 4 7 5 2 18 8 1
2020/2021131 3 7 3 3 38 5 8 3 6 3 7 45
2021/2022176 4 41 2 5 3 0 13 51 2 6 20 29
2022/2023350 25 69 4 25 33 34 1 21 119 0 12 7
2023/2024108 7 15 1 4 1 0 34 12 0 1 23 10
2024/20252 2 0 0 0 0 0 0 0 0 0 0 0
Totale 873